Author： Windler E.
Publisher： Springer Publishing Company
ISSN： 0020-9554
Source： Der Internist, Vol.45, Iss.11, 2004-11, pp. : 1315-1317
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Issues to debate on the Women’s Health Initiative study
Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. :
Access to resources
Recommend
Issues to debate on the Women’s Health Initiative
By Bódis J. Koppán M. Garai J. Zámbó K. Török A.
Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. :
Rosiglitazon und kardiovaskuläres Risiko
By Kintscher U.
Der Kardiologe, Vol. 1, Iss. 2, 2007-08 ,pp. :
Kardiovaskuläres Risiko unter Hormonersatztherapie
By Windler E.
Der Internist, Vol. 45, Iss. 7, 2004-07 ,pp. :